Carregant...

Validation of the EORTC QLQ-BIL21 questionnaire for measuring quality of life in patients with cholangiocarcinoma and cancer of the gallbladder

BACKGROUND: There is no specific quality of life (QoL) measurement tool to quantify QoL in patients with biliary tract cancer. Quality of life measurement is an increasingly crucial trial end point and is now being incorporated into clinical practice. METHODS: This International Multicentre Phase IV...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Kaupp-Roberts, S D, Yadegarfar, G, Friend, E, O'Donnell, C M, Valle, J W, Byrne, C, Bahar, I, Finch-Jones, M, Gillmore, R, Johnson, C D, Pereira, S P, Wiggers, J K, Pinto, M, Al-Sarireh, B, Ramage, J K
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5117782/
https://ncbi.nlm.nih.gov/pubmed/27673364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.284
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!